Literature DB >> 18373191

Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer.

Theresa Casey1, Jeffrey Bond, Scott Tighe, Timothy Hunter, Laura Lintault, Osman Patel, Jonathan Eneman, Abigail Crocker, Jeffrey White, Joseph Tessitore, Mary Stanley, Seth Harlow, Donald Weaver, Hyman Muss, Karen Plaut.   

Abstract

BACKGROUND: Breast cancer invasion and metastasis involves both epithelial and stromal changes. Our objective was to delineate the pivotal role stroma plays in invasion by comparing transcriptomes among stromal and epithelial cells in normal tissue and invasive breast cancer.
METHODS: Total RNA was isolated from epithelial and stromal cells that were laser captured from normal breast tissue (n = 5) and invasive breast cancer (n = 28). Gene expression was measured using Affymetrix U133A 2.0 GeneChips. Differential gene expression was evaluated and compared within a model that accounted for cell type (epithelial [E] versus stromal [S]), diagnosis (cancer [C] versus normal [N]) as well as cell type-diagnosis interactions.
RESULTS: Compared to NE, the CE transcriptome was highly enriched with genes in proliferative, motility and ECM ontologies. Differences in CS and NS transcriptomes suggested that the ECM was being remodeled in invasive breast cancer, as genes were over-represented in ECM and proteolytic ontologies. Genes more highly expressed in CS compared to CE were primarily ECM components or were involved in the remodeling of ECM, suggesting that ECM biosynthesis and remodeling were initiated in the tumor stroma.
CONCLUSION: Based on identified molecular cross-talk between the two contiguous cell populations, a mechanistic model that spurs invasion is proposed, that shows breast cancer invasion proceeds through the acquisition of a motile phenotype in tumor epithelial cells and a reactive phenotype in cancer associated fibroblasts.

Entities:  

Mesh:

Year:  2008        PMID: 18373191     DOI: 10.1007/s10549-008-9982-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  104 in total

1.  Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.

Authors:  Konstantin Knoblich; Hong-Xing Wang; Chandan Sharma; Anne L Fletcher; Shannon J Turley; Martin E Hemler
Journal:  Cell Mol Life Sci       Date:  2013-08-18       Impact factor: 9.261

2.  c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion.

Authors:  Liyang Wang; Yixuan Hou; Yan Sun; Liuyang Zhao; Xi Tang; Ping Hu; Jiajia Yang; Zongyue Zeng; Guanglun Yang; Xiaojiang Cui; Manran Liu
Journal:  Mol Oncol       Date:  2013-08-27       Impact factor: 6.603

Review 3.  Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.

Authors:  Jin G Jung; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 4.  One microenvironment does not fit all: heterogeneity beyond cancer cells.

Authors:  Ik Sun Kim; Xiang H-F Zhang
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

5.  Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer.

Authors:  Dorina Rama-Esendagli; Gunes Esendagli; Guldal Yilmaz; Dicle Guc
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

6.  The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; Badreddin Edris; Rui Li; Kelli Montgomery; Shirley Zhu; Sushama Varma; Robert J Marinelli; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

7.  Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples.

Authors:  Craig April; Brandy Klotzle; Thomas Royce; Eliza Wickham-Garcia; Tanya Boyaniwsky; John Izzo; Donald Cox; Wendell Jones; Renee Rubio; Kristina Holton; Ursula Matulonis; John Quackenbush; Jian-Bing Fan
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

8.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

9.  Breast tumour stroma is a prognostic indicator and target for therapy.

Authors:  Anthony Howell; Goran Landberg; Jonas Bergh
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

10.  Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast.

Authors:  M Bauer; G Su; C Casper; R He; W Rehrauer; A Friedl
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.